NRX Pharmaceuticals NRXP
NASDAQ NRXP
$2.90 +0.05 (+1.75%)
At close: Oct 2, 2026 · 4:00 PM EDT

NRX Pharmaceuticals (NRXP) Price to Sales (2025 - 2026)

Updated

NRX Pharmaceuticals' Price to Sales came in at 51.52 for Q2 2026, up 68.0% from the prior quarter.

Analysis

NRX Pharmaceuticals (NRXP) Price to Sales (2025 - 2026) Analysis & Trends

For FY2025, NRX Pharmaceuticals' Price to Sales was 47.35.

  • The five-year range for quarterly Price to Sales is 30.66 (Q1 2026) to 303.15 (Q3 2025).
  • Business Quant data shows NRXP's Price to Sales at 30.66 (Q1 2026), 47.35 (Q4 2025) and 303.15 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 NRX Pharmaceuticals 125.16 Mn 76.75 Mn 426,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 51.52
Mar 31, 2026 30.66
Dec 31, 2025 47.35
Sep 30, 2025 303.15
API Access

NRX Pharmaceuticals Price to Sales API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-sales&ticker=NRXP&period=max&api_key=YOUR_API_KEY